Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
about
Medical methods for mid-trimester termination of pregnancyMedical methods for first trimester abortionSurgical versus medical methods for second trimester induced abortionMedical methods for first trimester abortionContraceptive use of antiprogestin.From abortion to contraception in Europe.Antioxidant: a new role for RU-486 and related compoundsThe effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.Antiprogestins in gynecological diseases.Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens.Emergency contraception: an updated review.Medical approaches to termination of early pregnancy.Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.On the mechanism of action of RU486.Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.The use of prostaglandins and antiprogestins for pregnancy termination.Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review.RU-486: legal and policy issues confronting the Food and Drug Administration.RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.Efficacy of mifepristone for cervical priming for second-trimester surgical termination of pregnancy.Combination therapy with mifepristone and misoprostol for the management of first trimester miscarriage: Improved success.Development of medical termination of pregnancy: a review.Pattern of morbidity and mortality following illegal termination of pregnancy at Nnewi, Nigeria.Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.Clinical Use of Mifepristone (RU 486)
P2860
Q24234827-62D07D74-57F9-4E2D-9E0C-75914F28A703Q24235336-21407107-0A20-4320-8B08-166E5113E864Q24242713-4CB361BC-B824-4680-9A5B-87BB1796D67EQ24247370-13A3D615-E111-4847-BD96-7AC3795AFAF2Q33700142-4DEEC2BC-0F13-4A49-8079-A6AA72F93E34Q33921855-738F39FC-0D6F-427C-AFA1-C45ECB8073FDQ34157921-F7EA0827-BA85-408B-8FE7-17D7C676A9BEQ34438662-0811EB14-A599-49B6-9D3B-6EA2CED6AE04Q34587636-C33038D7-65ED-4430-8A1A-A3BC29DB2732Q34594132-D2055801-422C-4401-A4F5-B39364C20174Q34654865-D43D4114-E376-4874-AB95-6E84FA5B8531Q36800055-F45CC24F-4A35-4EDD-B508-99905E66C300Q37260979-4E0587A1-1574-4F13-A9D1-13972A195A3FQ37768739-3B43B179-FCB4-4550-87D1-E0D9C764D075Q37768740-241E7719-AB55-4173-A82B-93129E53F858Q38349318-E50F0A69-7CED-4D9C-A826-2BAA1FB5535FQ38966345-66DC9D0B-60A4-4B9D-BDD7-B8C1150AB5B9Q41078005-8D9431C7-D345-48E5-8122-C5A3A9893C3AQ41611347-C6A993F6-33A4-49F8-8C00-6D2EFB3E8E73Q42939293-A6F54B19-3432-452C-A4F8-4011AF140AFDQ45347477-C0606CFF-B9EA-485D-AB8A-FA6CEC87104DQ48247500-05DB626B-DE74-4F2C-9919-08919D18F97EQ50253360-AE9103AF-C49B-408F-9A57-EF9392EA29B3Q50636837-DEBE1733-EC02-4687-BD80-CF082338AA8FQ53534110-6776E535-A94A-4BBE-B31F-4F1C9B2413FCQ58244547-412AC255-0CD6-4E34-997D-F5B770E76EB3
P2860
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@en
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@nl
type
label
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@en
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@nl
prefLabel
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@en
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@nl
P1433
P1476
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
@en
P2093
P356
10.1016/0010-7824(85)90115-5
P577
1985-07-01T00:00:00Z